RxDoctor Payments Data

Christian Whittington, MD

Family Medicine · Conway, SCNPI 1588628663

Payments from drug & device makers

$813in general payments, 2019–2025

Across 49 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$277
  • AstraZeneca$98
  • Pfizer$64
  • AbbVie$54
  • Dexcom, Inc.$49
  • Bausch & Lomb Americas Inc.$42
  • plus $228 from 11 others

What the payments were for

  • Food & beverage$813100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$813 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$109,511
Medicare patients
494
Services billed
1,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide200$225,993
EliquisApixaban140$126,124
FarxigaDapagliflozin Propanediol113$119,300
JardianceEmpagliflozin76$77,410
JanuviaSitagliptin Phosphate78$72,149
TrulicityDulaglutide42$44,101
MounjaroTirzepatide33$36,197
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$33,256
EntrestoSacubitril/Valsartan22$17,013
XareltoRivaroxaban16$16,908
Bydureon BciseExenatide Microspheres14$16,588
Tresiba Flextouch U-100Insulin Degludec27$13,822
MyrbetriqMirabegron26$13,521
QuliptaAtogepant11$12,718
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,730

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$277$225,993200 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$98$134,783141 claims
PfizerEliquis, Premarin$64$128,796152 claims
Lilly USA, LLCTrulicity, Mounjaro$28$80,29975 claims
GSKTrelegy Ellipta, Breo Ellipta$29$42,62651 claims
Johnson & JohnsonXarelto$15$16,90816 claims
AbbVieQulipta$54$12,71811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Conway

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →